/ CORRECTION - Levi & Korsinsky, LLP
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 08/05/11 -- In the news release, "Levi & Korsinsky
Notifies Investors With Losses on Their Investment in Dendreon Corporation
of Class Action Lawsuit and the October 4, 2011 Lead Plaintiff Deadline,"
issued earlier today by Levi & Korsinsky, LLP, we are advised by the
company that the lead plaintiff deadline in the headline and fifth
paragraph should read "October 3, 2011" rather than "October 4, 2011" as
originally issued. Complete corrected text follows.
Levi & Korsinsky Notifies Investors With Losses on Their Investment in
Dendreon Corporation of Class Action Lawsuit and the October 3, 2011 Lead
Plaintiff Deadline
NEW YORK, NY -- August 5, 2011 -- Levi & Korsinsky announces that a class
action lawsuit has been commenced in the United States District Court for
the Western District of Washington at Seattle on behalf of purchasers of
Dendreon Corporation ("Dendreon") (NASDAQ: DNDN) who purchased shares
between January 7, 2011 and August 3, 2011 (the "Class Period").
To get more information, click here: .
The complaint alleges that during the Class Period, defendants issued
materially false and misleading statements regarding the Company's business
and operations. The complaint alleges that defendants knew or deliberately
disregarded the fact that financial forecasts regarding the immediate
adoption of the Company's cancer drug PROVENGE were dramatically inflated,
particularly in light of the fact that the Company had not provided
physicians with financing options. The complaint further alleges that
Dendreon lacked adequate systems of internal operational or financial
controls.
As a result of the aforementioned, shares of Dendreon traded at an
artificially high price. On August 3, 2011, Dendreon issued a press
release announcing financial and operational results well below analyst
expectations, and significantly lowered guidance for 2011. Following this
release, shares of Dendreon stock declined more than 60 percent.
If you are a member of the class and suffered a loss in Dendreon stock, you
have until October 3, 2011 to request that the Court appoint you as lead
plaintiff. Your ability to share in any recovery is not affected by the
decision whether or not to serve as a lead plaintiff. To obtain additional
information about your rights, contact Joseph E. Levi, Esq. either via
email at or by telephone at (877) 363-5972, or visit
.
Levi & Korsinsky has expertise in prosecuting investor securities
litigation and extensive experience in actions involving financial fraud
and represents investors throughout the nation, concentrating its practice
in securities and shareholder litigation Attorney advertising. Prior
results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 15th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.08.2011 - 15:50 Uhr
Sprache: Deutsch
News-ID 1028140
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Legal
Anmerkungen:
Diese Pressemitteilung wurde bisher 204 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"/ CORRECTION - Levi & Korsinsky, LLP
"
steht unter der journalistisch-redaktionellen Verantwortung von
Levi & amp; Korsinsky, LLP (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
